Home > Healthcare > Pharmaceuticals > Vaccines > Cancer Vaccine Market

Cancer Vaccine Market Share

Report ID: GMI10285
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Cancer Vaccine Market Share

The cancer vaccine sector is competitive in nature, with a mix of major global and smaller to medium-sized companies competing for market share. A pivotal aspect of market strategy involves the continual introduction of innovative products leveraging diverse technologies. Notably, prominent industry players command considerable influence in this dynamic landscape, often driving forward advancements through substantial investments in research and development. Stringencies in regulatory requirements for approval of new cancer vaccines and requirement for high initial capital investments creates hurdles for the newer players to enter into the market. Smaller players focus on specific therapies to compete with established players.

Cancer Vaccine Market Companies

Some of the eminent market participants operating in the cancer vaccine industry include:

Ayala Pharmaceuticals
AstraZeneca PLC
Amgen Inc.
Bristol-Myers Squibb Company
Dynavax Technologies Corporation
Dendreon Pharmaceuticals LLC
Ferring Pharmaceuticals
F. Hoffmann-La Roche Ltd
GeneReach Biotechnology Corp.
GSK plc
EOM Pharmaceutical Holdings, Inc.
Merck & Co., Inc.
Moderna, Inc.
OSG Immunotherapeutics
Sanofi

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Cancer vaccine market size was valued at USD 9.1 billion in 2023 and is estimated to grow at 11.2% CAGR from 2024 to 2032 driven by the rising prevalence of cancer.

The preventive vaccine segment in the market is expected to generate USD 15.5 billion by 2032 as preventing cancer through vaccination reduces the need for costly treatments.

U.S. cancer vaccine market is projected to reach USD 8.5 billion by 2032 owing to the increasing prevalence of cancer in the country

Ayala Pharmaceuticals, AstraZeneca PLC, Amgen Inc., Bristol-Myers, Squibb Company, Dynavax Technologies Corporation, Dendreon Pharmaceuticals LLC, Ferring Pharmaceuticals, and F. Hoffmann-La Roche Ltd among others.